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Objectives: Lipid peroxidation and hyperglycemia are common signs for diabetes. Natural 
antioxidants such as Spirulina platensis microalgae (SPM) may prevent lipid peroxidation 
and hyperglycemia. This study aimed to evaluate the effects of SPM on antioxidant and anti-
inflammatory in diabetic rats.
Materials and methods: Sixty-four rats were divided into eight groups (n=8) and orally 
treated with 0, 10, 20 and 30 mg/kg body weight of SPM extract. Experimental groups included 
diabetic rats fed with 0 (DC), 10, 20 and 30 mg/kg SPM. Healthy rats were treated with 0 mg/kg 
SPM (HC), 10 mg/kg SPM, 20 mg/kg SPM and 30 mg/kg SPM. At the end of the trial, blood 
samples were collected and the plasma concentrations of trace minerals (TMs), biochemical 
parameters, and antioxidant enzymes in liver were evaluated. Aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), TNF-α (tumor necrosis factor-alpha) and IL-6 (interleukin-6) 
were evaluated.
Results: Our findings showed that diabetes significantly lowered the plasma concentration of 
TMs and antioxidant enzymes in liver and also increased the levels of malondialdehyde, glucose, 
lipid profile, AST, ALT, TNF-α and IL-6 (DC vs HC). However, an oral supplement of SPM (20 
and 30 mg/kg body weight) lowered levels of malondialdehyde level, glucose, lipid parameters, 
AST, ALT, TNF-α and IL-6. The same levels increased the plasma contents of zinc, iron, copper 
and selenium and activity of antioxidant enzymes (P<0.05).
Conclusion: It can be concluded that diabetes decreases TM concentration and antioxidant 
enzymes and also increases lipid profile, glucose, AST, ALT, TNF-α and IL-6 concentrations. 
Inclusion of SPM supplementing (20 and 30 mg/kg body weight) increased some TMs and 
antioxidant enzymes. SPM may provide TMs for synthesis of antioxidant enzymes which sub-
sequently reduce lipid profile, glucose concentration and anti-inflammatory responses.
Keywords: antioxidant enzymes, diabetes, lipid profile, plasma selenium, Spirulina platensis
Introduction
Diabetes mellitus is a disease with multiple etiologies which has signs such as hypergly-
cemia and disturbances in carbohydrate, fat and protein metabolism. These disturbances 
are due to deficiencies in insulin secretion, insulin activity and/or both. In the long 
term, diabetes can cause problems such as disturbances in various organs. Some studies 
have shown a relation among trace elements (TMs), diabetes mellitus1 and changes in 
nutrient metabolism.2–5 Individuals with diabetes have reported to have inflammatory 
cytokines.6 Some TMs such as chromium, magnesium, vanadium, zinc, manganese, 
molybdenum and selenium can proteinate insulin activity.7 Zinc modulates insulin 
synthesis and storage and protects the structural integrity of insulin.3  Magnesium has 
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a critical role in phosphorylation reactions of glucose and its 
metabolism. Magnesium is involved in insulin resistance, car-
bohydrate tolerance, and dyslipidemia.8 Chromium as a trace 
mineral improves insulin activity through enhancing intracel-
lular signaling.9 TMs are essential for some activities in the 
body and they affect the pathogenesis of diabetes mainly by 
their role in peroxidation and inflammation. In addition, it 
was reported that diabetes markedly elevated the serum level 
of glucose.10 Montilla et al10 stated that hyperglycemia can 
create injuries in tissues and the brain, which subsequently 
may increase glucose excretion. Hypertriglyceridemia and 
hypercholesterolemia are the most common lipid abnormali-
ties in diabetes,11 and are related to glucose intolerance.12 
Oxidative stress and reactive oxygen species production can 
decompose lipids and cause lipid peroxidation and lipolysis. 
Oxidative stress is dominant when antioxidant defense sys-
tems are defaulted.13 Previous studies have shown reduced 
antioxidant enzyme activity in diabetic animals compared 
with control animals.14 We believe that some functional foods, 
eg, Spirulina platensis microalgae (SPM), may improve lev-
els of some TMs.15 SPM lipopeptides have a major role in 
physiological functions, eg, cytotoxic, antitumor, antiviral, 
antibiotic, antimalarial, antimycotic, multidrug resistance 
reversing, antifeedant, herbicide, and immunosuppressive 
factors.16 SPM, in a dose-dependent manner, decreased the 
metabolic activity of functional neutrophils, showing that 
SPM has anti-inflammatory activity.17 It contains more iron, 
magnesium, copper and zinc than other TMs. Antioxidants 
can help to prevent diabetes or alleviate the negative effects 
of diabetes on blood parameters and inflammatory phase. It 
is well accepted that antioxidants inhibit lipid peroxidation 
and subsequently alleviate harmful effects of diabetes on 
lipids and glucose. We hypothesized that diabetes reduces 
TMs, and SPM supplementing increases the required ele-
ments for synthesis of antioxidants; on the other hand, anti-
oxidants can prevent lipid peroxidation and overproduction 
of pro-inflammatory cytokines. Thus, the present study 
was conducted to investigate the antioxidant mechanism of 
SPM on TMs and its effects on blood biochemical and anti-
inflammatory parameters.
Materials and methods
animals
Sixty-four male Wistar rats, 200±20 g and 2.5 months of age 
at the start of the trial, were kept at room temperature (25°C) 
and under a light cycle of 12 hours light/12 hours dark for 
5 weeks. All rats had ad libitum access to a standard pellet 
diet (Javaneh Khorasan Company, Mashhad, Iran) and water. 
The pellet composition was as follows: 20% protein, 3% 
fat, 4% ash and 6% fiber. All experiments were approved 
by the Ethical Committee of IAU University, Kerman, Iran 
(IAUKB-1105). The experiments were conducted in accor-
dance with the National Institutes of Health Guide (NIH 
Publication No. 85–23, revised 1996) for the Care and Use 
of Laboratory Animals.
Pilot study
After 24 hours fasting, 36 Wistar rats were divided into four 
groups (each group six animals) and animals orally received 
0.3 mL distilled water, and SPM extract (20, 40 and 60 mg/
kg of body weight). The animals were monitored in order to 
evaluate the behavioral responses, toxicity signs and mortality 
for 24 hours. No mortality or toxicity signs were observed; 
thus we used levels of 10, 20 and 30 mg/kg.
experimental treatments
Streptozotocin (STZ; Sigma-Aldrich, St Louis, MO, USA) 
was used in order to induce diabetes mellitus in rats, as 
explained by Armstrong and Al-Awadi.19 Diabetes was 
induced by intraperitoneal injection of STZ (55 mg/kg BW). 
It was first dissolved in citrate buffer (pH 4.5, 0.1 mol/L triso-
dium citrate, 0.1 mol/L citric acid). Diabetes was confirmed 
after measurement of blood glucose levels, three days after 
the STZ injection. Rats with plasma glucose level higher than 
250 mg/dL were considered as diabetic. Glucose level was 
assessed using a kit from Pars Azmoon (Tehran, Iran). After 
induction of diabetes, rats were divided into two sections 
including healthy and diabetic. Animals were orally treated 
with microalgae (10, 20 and 30 mg/kg of body weight). Con-
trol rats were also treated with 0.3 mL distilled water. Each 
10 mg of microalgae was diluted in 2 mL distilled water and 
then orally administrated. Experimental treatments were as 
follows. Healthy rats fed with SPM at 10, 20 and 30 mg/kg 
of body weight were marked as SH10, SH20, and SH30, 
respectively. Rats treated with SPM at 10, 20 and 30 mg/kg 
of body weight were marked as SD10, SD20, and SD30 
respectively. Two healthy control (HC) and diabetic control 
(DC) groups were also considered. Therefore, animals were 
grouped into eight groups with eight rats per group. The SPM 
was purchased from Ghazaye Sabze Khalij Company (Bandar 
Abbas, Iran). The chemical composition of SPM is presented 
in Table 1. Chemical analysis of the SPM was done using 
the Association of Official Analytical Chemists (AOAC) 
method.18 Calibrations of trace minerals were performed 
with a series of mixtures containing graded concentrations 
of standard solutions of the same trace mineral.
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Blood samples
At 35 days of trials, all rats were anaesthetized and blood 
samples were collected from the tail vein in order to mea-
sure the blood biochemical parameters and TMs. The blood 
samples were transferred into tubes containing heparin for 
measurement of blood biochemical parameters and TMs, 
respectively. The samples were centrifuged at 2,000 g for 
5 minutes and plasma was separated. Blood parameters 
were determined by the Pars Azmoon kit. The samples 
were analyzed using commercial kit (Pars Azmoon) in 
order to measure the triglycerides, glucose, cholesterol and 
low-density lipoprotein (LDL). Aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) were assessed by 
auto-analyzer apparatus (Gesan Production Srl, Campobello 
di Mazara (TP), Italy). The samples were evaluated for the 
concentration of TNF-α (tumor necrosis factor-alpha) and 
IL-6 (interleukin-6) by specified kits of Abcam (Cambridge, 
UK), as recommended by manufacturer’s instructions. Levels 
of plasma TMs were evaluated by atomic absorption spectro-
photometer. Calibrations of trace minerals were performed 
with a series of mixtures containing graded concentrations 
of standard solutions of the same trace mineral.
activity of antioxidant enzymes and 
malondialdehyde (MDa)
After blood sampling, animals were anesthetized by ket-
amine. The liver was separated and liver tissues were washed 
in ice-cold 0.9% saline (w/v), then weighed and stored at 
–70°C. Activities of superoxide dismutase (SOD), gluta-
thione peroxidase (GSH-Px) and catalase (CAT) and also 
levels of MDA were measured as previously explained by 
Bukan et al.14
Statistical analysis
The data were analyzed by GraphPad Prism statistical soft-
ware (GraphPad Software, Inc., La Jolla, CA, USA) and 
the data were analyzed by one-way analysis of variance 
(ANOVA) with Dennett’s multiple comparison posttest. 
Treated and non-treated rats in each section were compared 
by Dennett’s multiple comparisons posttest. Healthy rats were 
compared with diabetic rats in the same group by Student’s 
t-test. For example, control healthy rats were compared with 
control diabetic rats and data are presented in tables. The 
results are presented as mean±SD. A value of P<0.05 was 
considered to be statistically significant.
Results
Our findings in Table 2 showed that diabetes reduced the 
plasma concentration of TMs (P<0.05: DC vs HC), but oral 
supplementing with SPM (20 and 30 mg/kg body weight) 
significantly increased the plasma concentrations of zinc, 
iron, selenium and copper (P<0.05). Treatment with SPM 
did not improve other TMs. The plasma concentrations of 
TMs were not influenced by SPM supplementing in healthy 
rats (P>0.05). Results (Tables 3 and 4) showed that diabetes 
significantly increased the plasma concentrations of glucose, 
triglycerides, cholesterol, LDL, ALT, AST, TNF-α and IL-6. 
However, rats treated with SPM (20 and 30 mg/kg body 
weight) showed the lower plasma concentrations of glucose, 
triglycerides, cholesterol, LDL, ALT, AST, TNF-α and IL-6 
compared with DC. Our findings indicated that diabetes 
lowered activity of antioxidant enzymes and increased MDA 
levels compared with HC (P<0.05). Similar to the above find-
ings, oral supplementing with SPM at levels of 20 and 30 
mg/kg body weight increased activity of antioxidant enzymes 
and lowered MDA levels (P<0.05).
Discussion
Our findings showed that diabetes significantly lowered the 
plasma concentration of TMs. Comparing the data for HC and 
DC groups showed that diabetes decreases the plasma concen-
trations of TMs. The data for TMs were as follows: for zinc 
(58.50±2.07 vs 35.75±1.66), iron (28.10±2.07 vs 15.75±1.66), 
magnesium (48.50±3.07 vs 36.75±3.32), copper (28.38±0.74 
vs 16.50±1.85), selenium (13.38±0.51 vs 8.00±0.75), and 
chromium (23.38±0.75 vs 18.28±0.51). Studies have shown 
that deficiencies in zinc and chromium levels may cause glu-
cose intolerance and insulin resistance.20,21 Zinc is an essential 
cofactor for SOD, which acts as an intracellular antioxidant 
enzyme. It has been suggested that pancreatic beta cells have 
low antioxidative enzyme activities which might be more sen-
Table 1 chemical composition of SPM
Components Amount
Dry matter (%) 95
ether extract (%) 5.3
crude protein (%) 61.8
Crude fiber (%) 9.5
ash (%) 6.9
ca (mg/100 g) 500
P (mg/100 g) 800
Fe (mg/100 g) 90
K (mg/100 g) 1,235
Mg (mg/100 g) 195
cu (mg/100 g) 20
Zn (mg/100 g) 15
Se (mg/100 g) 1
cr (mg/100 g) 1
Abbreviation: SPM, Spirulina platensis microalgae.
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sitive to free radicals, especially in zinc deficiency.22 Similarly, 
chromium has a role as a modulator in diabetes,23 glucose 
intolerance,24 and corticosteroid-induced diabetes.25 Mag-
nesium is a trace  element involved in glucose  homeostasis, 
so there is a positive correlation between magnesium and 
glucose metabolisms. Magnesium has an important role in 
insulin action, and insulin stimulates magnesium uptake in 
insulin-sensitive tissues. Intracellular magnesium deficiency 
Table 2 effect of SPM at different levels on TMs concentration (µmol/l)
Zinc Iron Magnesium Copper Selenium Chromium
Groups
HC 58.50±2.07a 28.10±2.07a 48.50±3.07a 28.38±0.74a 13.38±0.51a 23.38±0.75a
SH10 57.38±1.40a 27.38±1.40a 47.38±1.40a 28.13±0.64a 13.38±0.53a 23.42±0.51a
SH20 57.13±1.24a 27.13±1.24a 47.13±1.24a 27.50±0.53a 13.38±0.74a 23.25±0.71a
SH30 58.00±1.19a 28.00±1.19a 48.00±1.19a 28.00±1.19a 13.38±0.62a 23.52±0.93a
DC 35.75±1.66c 15.75±1.66c 36.75±3.32b 16.50±1.85c 8.00±0.75c 18.28±0.51b
SD10 36.75±1.38c 16.75±1.38c 35.25±4.86b 17.25±1.28c 8.20±0.71c 18.78±0.42b
SD20 45.38±1.91b 23.75±1.90b 38.50±2.07b 22.50±1.30b 9.75±1.28bc 18.58±0.91b
SD30 46.00±2.07b 25.00±3.38a 36.38±3.07b 23.75±1.75b 11.13±0.83b 13.38±0.51b
P-value *** *** *** *** *** ***
Notes: Subscripts (a–c) show significant differences among groups per column and *** shows significant differences at P<0.001.
Abbreviations: SPM, Spirulina platensis microalgae; TM, trace minerals.
Table 3 Effect of SPM at different levels on some lipid profiles and glucose concentration (mg/dL) and liver enzymes (U/L)
Triglycerides Cholesterol LDL-C Glucose AST ALT
Groups
HC 38.70±3.07c 70.15±8.50c 32.60±5.07c 135.20±11.50c 98.20±11.50c 85.20±7.50c
SH10 39.38±2.45c 68.20±7.40c 34.50±3.40c 141.20±12.50c 97.10±10.50c 83.20±5.15c
SH20 37.23±2.24c 69.50±6.50c 35.50±2.44c 139.80±10.90c 98.10±10.50c 82.10±7.15c
SH30 38.20±2.29c 67.50±5.15c 38.00±3.55c 135.70±9.40c 99.10±11.50c 84.40±9.15c
DC 68.78±4.76a 108.5±10.66a 65.10±5.31a 279.00±18.40a 310.10±17.50a 145.40±12.14a
SD10 66.75±3.38a 99.50±9.61a 63.21±3.66a 269.50±14.50a 298.10±17.50a 149.40±9.14a
SD20 55.38±2.90b 70.50±7.10b 45.50±3.07b 205.20±15.70b 265.10±15.50b 119.40±9.14b
SD30 54.10±2.07b 68.10±5.15b 42.61±5.07b 195.50±11.50b 268.10±17.30b 121.40±7.14b
P-value *** *** *** *** *** ***
Notes: Subscripts (a–c) show significant differences among groups per column and *** shows significant differences at P<0.001.
Abbreviations: SPM, Spirulina platensis microalgae; TM, trace minerals; lDl, low-density lipoprotein; aST, aspartate aminotransferase; alT, alanine aminotransferase.
Table 4 effect of SPM at different levels on liver SOD (U/mg protein), gSh-Px (U/mg protein), caT (K/mg protein), MDa levels 
(nmol/g tissue) and pro-inflammatory cytokines (pg/mL)
SOD GSH-Px CAT MDA TNF-a IL-6
Groups
HC 30.50±2.25a 10.50±1.50a 0.34±0.05a 22.50±1.50c 5.10±0.50c 4.50±0.40c
SH10 29.45±1.45a 11.20±1.40a 0.33±0.06a 21.50±1.70c 5.30±0.60c 4.80±0.50c
SH20 28.25±1.25a 10.50±1.50a 0.34±0.02a 23.50±1.90c 5.20±0.15c 5.10±0.50c
SH30 28.80±1.30a 10.80±1.10a 0.35±0.05a 24.10±2.40c 5.10±0.4c 5.50±1.00c
DC 21.80±2.75c 7.50±1.50b 0.19±0.01c 29.50±2.40a 10.50±0.50a 10.50±1.00a
SD10 22.75±2.35c 8.10±0.90b 0.18±0.04c 28.70±1.50a 12.30±0.70a 9.60±1.30a
SD20 26.45±1.90b 9.50±2.10a 0.26±0.04b 25.50±1.10b 8.50±0.50b 7.50±1.10b
SD30 26.40±1.50b 10.50±0.90a 0.27±0.02b 25.10±0.90b 8.10±0.70b 7.50±0.80b
P-value *** *** *** *** *** ***
Notes: Subscripts (a–c) show significant differences among groups per column and *** shows significant differences at P<0.001.
Abbreviations: SOD, superoxide dismutase; gSh-Px, glutathione peroxidase; caT, catalase; MDa, malondialdehyde; TnF-α, tumor necrosis factor-alpha.
may affect the development of insulin resistance and alter the 
glucose entry into the cell. Magnesium is required for both 
proper glucose utilization and insulin signaling.26 Metabolic 
alterations in cellular magnesium, which may play the role of 
a second messenger for insulin action, contribute to insulin 
resistance.26,27 Selenium plays a main role in the antioxidant 
system by participation in glutathione peroxidases, thiore-
doxin reductase, and iodothyronine deiodinase. In view of 
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its important function in protection against oxidative stress, 
selenium was suggested to play a protective role against dia-
betes.28,29 All the mentioned studies clearly state modulation of 
TMs in diabetes. Our findings also showed decreased levels of 
TMs during diabetes. As mentioned, TM deficiency influences 
diabetes mellitus, but TMs may help patients with diabetes 
mellitus. However, oral supplementing with SPM (20 and 30 
mg/kg body weight) increased the plasma concentrations of 
zinc, iron, copper and selenium. The reason why SPM at high 
levels increases levels of zinc, iron, copper and selenium is 
unknown. SPM may help to more absorption of TMs which 
may increase TMs concentration in plasma.
Diabetes increased the plasma concentrations of choles-
terol, triglycerides, LDL-C and glucose. Comparing the data 
for HC and DC shows the differences clearly. The data were 
as follows: for cholesterol (70.15±8.50 vs 108.5±10.66), tri-
glycerides (38.70±3.07 vs 68.78±4.76), LDL-C (32.60±5.07 
vs 65.10±5.31), glucose (135.20±11.50 vs 279.00±18.40), 
ALT (85.20±7.50 vs 145.40±12.14) and AST (98.20±11.50 vs 
310.10±17.50). Previous reports showed that STZ markedly 
increased the serum level of glucose.10 Montilla et al10 have 
reported that hyperglycemia can cause injuries in tissues and 
brain which subsequently may increase glucose excretion. 
Hypertriglyceridemia and hypercholesterolemia are known 
as the most common lipid abnormalities in diabetes11 and are 
related to glucose intolerance.12 It is well known that oxidative 
stress and reactive oxygen species production can degrade 
lipids and cause lipid peroxidation and lipolysis. Oxidative 
stress contributes to many pathological conditions and dis-
eases, including cancer, neurological disorders, atherosclerosis, 
hypertension, ischemia and diabetes.13 Studies have reported 
that diabetes increases levels of ALT and AST in serum30 and 
kidney.31 Okada et al32 have reported that AST activity was 
significantly lower in diabetic rat tissues, because of inactiva-
tion of cytosolic AST in the diabetic rat tissues by a glycation 
reaction and/or by faulty glucose utilization in STZ induced 
diabetes. In contrast to our findings, Khan et al33 have reported 
that dietary inclusion of microalgae did not change ALT and 
AST concentration in male rats. Our findings showed that 
higher levels of SPM decreased the plasma concentrations 
of cholesterol, triglycerides, LDL-C, glucose, ALT and AST. 
The oxygen species, as oxidants, are responsible for increased 
lipids and glucose. Antioxidants may interact with oxidants 
and thus alleviate their negative effects on lipid parameters, 
glucose concentration and liver enzymes. MDA is an index 
for lipid peroxidation and our findings showed (Table 4) that 
it was significantly decreased in SD20 and SD30. As Table 4 
shows, oral supplementing with SPM at higher levels increased 
antioxidant enzymes in liver. It seems that the increased levels 
of antioxidants interact with oxidants and partly alleviate nega-
tive effects of diabetes on lipids, glucose and liver enzymes. 
We believed that higher levels of SPM may provide essential 
TMs for synthesis of antioxidant enzymes, and, on the other 
hand, the increased levels of antioxidants decrease the plasma 
concentrations of glucose, lipid parameters, and liver enzymes 
and MDA. The role of some TMs in lowering glucose levels 
may be another reason for the reduced glucose, because higher 
levels of SPM increased some TMs. Interestingly, SPM had 
no significant effect on TM levels, antioxidant levels and 
blood biochemical parameters in healthy rats. In addition, our 
findings showed that SPM (20 and 30 mg/kg body weight) 
significantly alleviated adverse effects of diabetes on TNF-α 
and IL-6. These cytokines play significant roles in the patho-
genesis of diabetes. It has been reported that diabetes increases 
levels of inflammatory cytokines.6 Overproduction of ROS 
increases oxidative stress and inflammatory responses.34 A 
study has shown that SPM reversed increased proinflammatory 
cytokines in the cerebellum, such as TNF-α and TNF-β.17 It 
seems that SPM shows anti-inflammatory effects by reduc-
ing ROS. This means that SPM decreases pro-inflammatory 
cytokines by antioxidant properties. Our findings showed that 
SPM increased anti-inflammatory responses as it increased 
antioxidant properties, implying a positive correlation between 
antioxidant and anti-inflammatory properties in SPM. In 
summary, an overdose of TMs may have negative effects on 
animals’ heath; however, we did not observe toxicity effects 
of SPM at these levels on animals.
Conclusion
Our findings showed that diabetes significantly decreased 
the plasma concentration of TMs and antioxidant enzymes 
and also increased the plasma concentration of glucose, 
lipid parameters, MDA, ALT, AST, TNF-α and IL-6. Our 
results showed that oral supplementing with SPM, at high 
levels (20 and 30 mg/kg body weight), increased the plasma 
concentration of zinc, iron, selenium and copper. The higher 
levels of SPM (20 and 30 mg/kg body weight) also increased 
the plasma antioxidant enzymes and also lowered the plasma 
concentration of glucose, lipid parameters, MDA, ALT, AST, 
TNF-α and IL-6. It seems that oral supplementing of SPM 
(20 and 30 mg/kg body weight) may supply essential TMs 
for synthesis of antioxidant enzymes; on the other hand, 
increased levels of antioxidants enzymes can decrease MDA 
and the plasma concentration of lipids, glucose, MDA, ALT, 
AST, TNF-α and IL-6. It can be suggested to use SPM at 
higher levels as a supplement for treatment of diabetes. Since 
levels of 20 and 30 mg/kg had similar effects on mentioned 
parameters, we recommend using 20 mg/kg, because of 
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the lower cost. In addition, TMs have higher costs and may 
have toxicity effects in comparison to SPM. Thus, it can be 
recommended to use SPM instead of TMs.
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